• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期食管鳞状细胞癌纵隔镜下食管切除术的长期疗效:269例研究

Long-term outcomes of mediastinoscopic esophagectomy in early esophageal squamous cell carcinoma: 269 cases study.

作者信息

Zheng Liang, Zhang Xiaobin, Zhang Lei, Wang Qianyun, Wang Zhonglin

机构信息

Department of Cardiothoracic Surgery, The First People's Hospital of Changzhou and The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.

出版信息

Mediastinum. 2019 Sep 2;3:34. doi: 10.21037/med.2019.08.01. eCollection 2019.

DOI:10.21037/med.2019.08.01
PMID:35118262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8794451/
Abstract

BACKGROUND

Studies in larger populations and long-term outcomes of Mediastinoscopic esophagectomy (ME) were needed. The aim of this study was to report the long-term survival and surgical process for reducing the postoperative complications after ME.

METHODS

From December 2005 to March 2018, 269 patients diagnosed with esophageal squamous cell carcinoma were participated for ME in our center, while we improved the surgical process in November 1st 2014, clinical data was collected and analyzed.

RESULTS

The overall survival rate after ME was 60.3% at 10-year and 69.2% at 5-year, and the survival curve was markedly associated with T and N stages. N stage resulted in lower survival time, while the median survival was 36 months. After Nov. 2014, the positive rate of lymph nodes around left recurrent laryngeal nerve (LRLN) was increased from 6.7% to 14.5% (P<0.05), and the morbidity of vocal cord paralysis decreased from 9.8% to 3.9% (P<0.05), while the incidence of anastomotic fistula decreased from 15% to 5.3% in ME (P<0.05), compared with the data before Nov. 2014.

CONCLUSIONS

ME was an effective surgical method for esophageal cancer. The processes of isolating and marking the LRLN and reinforcing the posterior wall of anastomosis were proved valuable for improvement of postoperative complications.

摘要

背景

需要对更大规模人群进行纵隔镜下食管切除术(ME)的研究以及其长期预后情况。本研究的目的是报告ME术后的长期生存率以及为减少术后并发症所采取的手术过程。

方法

2005年12月至2018年3月,269例诊断为食管鳞状细胞癌的患者在本中心接受ME手术,2014年11月1日我们改进了手术过程,并收集分析了临床数据。

结果

ME术后10年总生存率为60.3%,5年为69.2%,生存曲线与T和N分期显著相关。N分期导致生存时间较短,中位生存时间为36个月。2014年11月之后,左侧喉返神经(LRLN)周围淋巴结阳性率从6.7%升至14.5%(P<0.05),声带麻痹发生率从9.8%降至3.9%(P<0.05),同时ME术中吻合口瘘发生率从15%降至5.3%(P<0.05),与2014年11月之前的数据相比。

结论

ME是治疗食管癌的一种有效手术方法。分离和标记LRLN以及加固吻合口后壁的操作被证明对改善术后并发症有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/fc54d752b490/med-03-34-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/e472a5df476a/med-03-34-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/868f271ae588/med-03-34-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/51335aa6e2ab/med-03-34-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/fc54d752b490/med-03-34-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/e472a5df476a/med-03-34-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/868f271ae588/med-03-34-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/51335aa6e2ab/med-03-34-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c50/8794451/fc54d752b490/med-03-34-f4.jpg

相似文献

1
Long-term outcomes of mediastinoscopic esophagectomy in early esophageal squamous cell carcinoma: 269 cases study.早期食管鳞状细胞癌纵隔镜下食管切除术的长期疗效:269例研究
Mediastinum. 2019 Sep 2;3:34. doi: 10.21037/med.2019.08.01. eCollection 2019.
2
Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment.经颈纵隔镜辅助淋巴结清扫术联合左开胸食管癌切除术与右开胸食管癌切除术治疗食管癌的疗效比较。
World J Surg Oncol. 2018 Feb 9;16(1):25. doi: 10.1186/s12957-017-1268-3.
3
Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer.单孔纵隔镜辅助经裂孔食管癌切除术治疗胸段食管癌的围手术期结果
Dis Esophagus. 2017 Oct 1;30(10):1-8. doi: 10.1093/dote/dox047.
4
Mediastinoscopic esophagectomy for patients with early esophageal cancer.早期食管癌患者的纵隔镜下食管切除术
J Thorac Dis. 2015 Jul;7(7):1235-40. doi: 10.3978/j.issn.2072-1439.2015.07.20.
5
[Clinical value of para-recurrent laryngeal nerve lymphadenectomy for middle thoracic esophageal squamous cell carcinoma].胸段中段食管鳞状细胞癌喉返神经旁淋巴结清扫术的临床价值
Zhonghua Wei Chang Wai Ke Za Zhi. 2015 Sep;18(9):867-70.
6
[Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].[Sweet术式与Ivor-Lewis术式治疗中下段食管鳞状细胞癌的疗效比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Sep 25;19(9):979-984.
7
A case of esophageal cancer with an aberrant right subclavian artery treated with mediastinoscopic esophagectomy.一例因异常右锁骨下动脉而行胸腔镜食管切除术的食管癌病例。
Asian J Endosc Surg. 2021 Apr;14(2):293-296. doi: 10.1111/ases.12859. Epub 2020 Aug 26.
8
[Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].[胸段食管鳞状细胞癌两野与三野淋巴结清扫术的疗效比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Sep 25;19(9):990-994.
9
Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-term outcomes.机器人辅助微创食管切除术在治疗食管鳞癌方面真的比电视辅助微创食管切除术具有淋巴结清扫优势吗?基于短期结果的倾向评分匹配分析。
Dis Esophagus. 2019 Jul 1;32(7). doi: 10.1093/dote/doy110.
10
A feasibility study of mediastinoscopic radical esophagectomy for thoracic esophageal cancer from the viewpoint of the dissected mediastinal lymph nodes validated with thoracoscopic procedure: a prospective clinical trial.从经胸腔镜手术验证的纵隔淋巴结清扫角度对纵隔镜根治性食管癌切除术治疗胸段食管癌的可行性研究:一项前瞻性临床试验
Esophagus. 2019 Apr;16(2):214-219. doi: 10.1007/s10388-018-00656-7. Epub 2019 Feb 8.

本文引用的文献

1
Long-term outcomes following minimally invasive and open esophagectomy in Finland: A population-based study.芬兰微创与开放食管切除术的长期结果:一项基于人群的研究。
Eur J Surg Oncol. 2019 Jun;45(6):1099-1104. doi: 10.1016/j.ejso.2018.12.001. Epub 2018 Dec 7.
2
The management of mid & proximal oesophageal squamous cell carcinoma.中近端食管鳞癌的治疗管理。
Best Pract Res Clin Gastroenterol. 2018 Oct-Dec;36-37:85-90. doi: 10.1016/j.bpg.2018.11.012. Epub 2018 Nov 30.
3
Global time trends in the incidence of esophageal squamous cell carcinoma.
食管鳞状细胞癌发病率的全球时间趋势。
Clin Epidemiol. 2018 Jun 19;10:717-728. doi: 10.2147/CLEP.S166078. eCollection 2018.
4
Surgical evaluation of lymph nodes in esophageal adenocarcinoma: Standardized approach or personalized medicine?食管腺癌淋巴结的外科评估:标准化方法还是个体化医学?
Eur J Surg Oncol. 2018 Aug;44(8):1177-1180. doi: 10.1016/j.ejso.2018.03.007. Epub 2018 Apr 19.
5
Short-Term Outcomes Following Minimally Invasive and Open Esophagectomy: A Population-Based Study from Finland and Sweden.微创与开放性食管切除术的短期疗效:来自芬兰和瑞典的基于人群的研究。
Ann Surg Oncol. 2018 Jan;25(1):326-332. doi: 10.1245/s10434-017-6212-9. Epub 2017 Nov 1.
6
Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis.微创与开放食管癌切除术治疗食管癌:一项基于人群的分析。
Ann Thorac Surg. 2016 Aug;102(2):416-23. doi: 10.1016/j.athoracsur.2016.02.078. Epub 2016 May 4.
7
Mediastinoscopic esophagectomy for patients with early esophageal cancer.早期食管癌患者的纵隔镜下食管切除术
J Thorac Dis. 2015 Jul;7(7):1235-40. doi: 10.3978/j.issn.2072-1439.2015.07.20.
8
Single-Port Mediastinoscopic Lymphadenectomy Along the Left Recurrent Laryngeal Nerve.沿左侧喉返神经行单孔纵隔镜下淋巴结切除术
Ann Thorac Surg. 2015 Sep;100(3):1115-7. doi: 10.1016/j.athoracsur.2015.03.122.
9
Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.食管癌手术后淋巴结清扫范围与预后
JAMA Surg. 2016 Jan;151(1):32-9. doi: 10.1001/jamasurg.2015.2611.
10
Extent of lymph node removal during esophageal cancer surgery and survival.食管癌手术中淋巴结清扫的范围与生存。
J Natl Cancer Inst. 2015 Mar 5;107(5). doi: 10.1093/jnci/djv043. Print 2015 May.